Landscape Capital Management L.L.C. Lowers Position in The Cooper Companies, Inc. $COO

Landscape Capital Management L.L.C. lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 33.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 38,160 shares of the medical device company’s stock after selling 19,009 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in Cooper Companies were worth $3,128,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of COO. Root Financial Partners LLC lifted its holdings in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares in the last quarter. Bell Investment Advisors Inc lifted its holdings in shares of Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies in the second quarter worth $36,000. True Wealth Design LLC lifted its holdings in shares of Cooper Companies by 484.8% in the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after buying an additional 383 shares in the last quarter. Finally, Cromwell Holdings LLC lifted its holdings in shares of Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after buying an additional 273 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the topic of several research reports. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. BNP Paribas Exane reduced their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Stifel Nicolaus reduced their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Finally, Barclays boosted their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $82.64.

Cooper Companies Price Performance

NASDAQ:COO opened at $67.88 on Monday. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a 50-day moving average of $64.79 and a 200 day moving average of $74.34. The firm has a market cap of $13.24 billion, a PE ratio of 57.53, a price-to-earnings-growth ratio of 1.78 and a beta of 0.88. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the firm earned $0.96 earnings per share. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.